1. Home
  2. TDOC vs MPLT Comparison

TDOC vs MPLT Comparison

Compare TDOC & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teladoc Health Inc.

TDOC

Teladoc Health Inc.

HOLD

Current Price

$6.77

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$30.25

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TDOC
MPLT
Founded
2002
2018
Country
United States
United States
Employees
N/A
133
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
TDOC
MPLT
Price
$6.77
$30.25
Analyst Decision
Buy
Strong Buy
Analyst Count
18
7
Target Price
$7.56
$32.67
AVG Volume (30 Days)
5.1M
275.5K
Earning Date
04-29-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
80.58
N/A
EPS
N/A
N/A
Revenue
$2,406,840,000.00
N/A
Revenue This Year
$1.19
N/A
Revenue Next Year
$1.25
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.41
N/A
52 Week Low
$4.40
$12.24
52 Week High
$9.77
$33.28

Technical Indicators

Market Signals
Indicator
TDOC
MPLT
Relative Strength Index (RSI) 64.27 56.58
Support Level $6.74 $26.70
Resistance Level $7.95 $32.68
Average True Range (ATR) 0.38 2.54
MACD 0.07 -0.43
Stochastic Oscillator 72.45 62.04

Price Performance

Historical Comparison
TDOC
MPLT

About TDOC Teladoc Health Inc.

Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: